Enesi Pharma
Chemicals & Related Products · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
120 A&b Olympic Ave Milton Park, Abingdo...Phone Number
+44 1235577120Website
www.enesipharma.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Enesi Pharma
Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies. These diseases affect millions of people around the world. We work in partnership with global companies, government agencies, leading academic institutions and non-governmental organisations with the goal of making a material and lasting positive impact on global health. Our award-winning ImplaVax®-enabled vaccination products leverage our innovative unit solid-dose formulation and needle-free delivery technologies and are applicable across all vaccine formats. ImplaVax® products are designed to enhance the immune response and offer significant benefits for patients, care givers, healthcare professionals and payers through enhanced effectiveness, safety, ease of use, reliability and stability, coupled with a strong subject preference over administration using needle and syringe. They do not require reconstitution prior to useRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Enesi Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Enesi Pharma
Enesi Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Enesi Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Enesi Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Enesi Pharma launches new products
Funding: Get notified immidiatlly once Enesi Pharma has new funding data
Check out if Enesi Pharma is spiking on competitors!
Check if Enesi Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Enesi Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Enesi Pharma
Compare insights from companies similar to Enesi Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Enesi Pharma
$7M
11-50
Private
<$5M
2017
N/A
Company Profile Activity
Activity Insights
Enesi Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Enesi Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Enesi Pharma.
Enesi Pharma financials insights
Gather financial insights about Enesi Pharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Grant
$1.1M
Enesi Pharma Tech Stack
A closer look at the technologies used by Enesi Pharma
Enesi Pharma News & Media
Enesi Pharma appoints Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations
OXFORD, England, Sept. 7, 2021 /PRNewswire/ -- Enesi Pharma Ltd ("Enesi"), an innovative biotechnology company developing next-generation vaccination products, targeting infectious diseases and emergent threat pathogens, enabled by its world leading ImplaVax® technologies, is delighted to...Enesi Pharma's ImplaVax®-Enabled, Solid-Dose Recombinant Classical Swine Fever (CSF) Vaccine Produces Immune Responses Superior to Liquid Vaccine
OXFORD, England, May 6, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, is delighted to report positive...Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella
OXFORD, England, May 5, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces it has achieved a key...Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax®-Enabled Pandemic Influenza Vaccine
OXFORD, England, May 4, 2021 /PRNewswire/ -- Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces that it has successfully...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Enesi Pharma
Sign Up For FreeTo access detailed company insights
Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies. These diseases affect millions of people around the world. We work in partnership with global companies, government agencies, leading academic institutions and non-governmental organisati... Read More
